CCL2 and chronic obstructive pulmonary disease: MCP-1 can also recruit macrophages, neutrophils, and lymphocyte inflammatory cells to the lungs, thereby increasing proinflammatory cytokine secretion, tissue inflammation, and COPD disease severity (26).